Royal Jelly acid

CAS No. 14113-05-4

Royal Jelly acid( —— )

Catalog No. M18005 CAS No. 14113-05-4

10-Hydroxy-2-decenoic acid is an inhibitor of VEGF-induced angiogenesis, cell migration and proliferation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 32 In Stock
25MG 29 In Stock
50MG 40 In Stock
100MG 58 In Stock
200MG Get Quote In Stock
500MG 118 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Royal Jelly acid
  • Note
    Research use only, not for human use.
  • Brief Description
    10-Hydroxy-2-decenoic acid is an inhibitor of VEGF-induced angiogenesis, cell migration and proliferation.
  • Description
    10-Hydroxy-2-decenoic acid is an inhibitor of VEGF-induced angiogenesis, cell migration and proliferation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    14113-05-4
  • Formula Weight
    186.25
  • Molecular Formula
    C10H18O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (536.91 mM)
  • SMILES
    C(CCC/C=C/C(=O)O)CCCO
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Yang XH, et al. Comparative proteomic analysis provides insight into 10-hydroxy-2-decenoic acid biosynthesis in honey bee workers. Amino Acids. 2017 Apr 17.
molnova catalog
related products
  • BMS-818251

    BMS-818251 (BMS818251) is a novel potent, small-molecule inhibitor of HIV-1 entry with EC50 of 0.019 nM against e laboratory-adapted HIV-1 strain NL4-3.

  • Isoxanthohumol

    Isoxanthohumol shows an antiviral activity towards herpes viruses (HSV1 and HSV2) and bovine viral diarrhea virus (BVDV).

  • GS-6207

    GS-6207 (GS6207, GS-CA1) is a potent, selective inhibitor of HIV-1 capsid function with potency and potential to be clinically effective against a broad range of HIV-1 strains.